| Name | Title | Contact Details |
|---|
CareJourney is a leading provider of clinically-relevant analytics for value-based networks. Headquartered in Arlington, VA, CareJourney currently supports leading payer, provider, and life sciences organizations across the US in achieving their goals by wringing new, high value insights out of expansive population claims data. Through its CareJourney Platform, CareJourney provides members with interactive dashboards of clinically-relevant insights around network design and management, care model management, patient risk segmentation, spend and utilization trends, network integrity, low-value care, and provider, practice and facility (acute and post-acute) performance.
Renaissance ClubSport is a Walnut Creek, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Westside Health Inc is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ConnectYourCare’s comprehensive and flexible consumer-directed health care (CDH) solution provides a fast path to account-based health plans like Health Savings Accounts (HSA), Flexible Spending Accounts (FSA), Health Reimbursement Arrangements (HRA) and other tax-advantaged benefit accounts including COBRA, Transportation and Adoption Assistance. We help businesses lower benefit costs while empowering consumers to achieve health care savings with simple, powerful tools and a robust suite of educational materials. The solution of choice for brokers, employers, health plans and banks, ConnectYourCare’s smartCDH™ technology platform offers a fresh approach to health savings by combining a simplified experience and seamless access. Developed with all tax-advantaged savings accounts in mind, smartCDH works with equal precision across all account types – and those still to come. By removing complexity and motivating individuals to take control of health savings, ConnectYourCare maximizes return on investment for all participants in the health care benefits marketplace.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.